Inventor

KIM IN-SAN

KR32 patents

⚠️ This page may combine multiple inventors who share the name “KIM IN-SAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KIM IN-SAN

KOREA INST SCI & TECH

Exosome-based anticancer agent

Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof

Nanocage and use thereof

Drug-fluorophore complex for specific detection of tumor cells

Immunoregulatory protein-siRNA complex having anticancer activity

KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND

Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof

Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient

Ferritin nanocage for multi-displaying trail trimer and cancer-targeting peptide and use thereof as anticancer agent

Human-derived ferritin monomer fragment and fusion polypeptide using same

Human ferritin-derived fusion polypeptide

KYUNGPOOK NAT UNIV IND ACAD

Bladder tumor-targeting peptide and use thereof

Use of a peptide that interacts with αvβ3 integrin of endothelial cell

Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof

Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides

REGEN BIOTECH INC

Method for cell adhesion and wound healing

Peptides and derivatives thereof showing cell attachment, spreading and detachment activity

Peptides and derivatives thereof showing cell attachment, spreading and detachment activity

Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers

KIST KOREA INSTITUTE OF SCIENCE AND TECH

Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell

Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell

Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell

SEOUL NAT UNIV R&DB FOUNDATION

Methods of inhibiting pathological angiogenesis with doppel-targeting molecules

Methods of inhibiting pathological angiogenesis with doppel-targeting molecules

LEE BYUNG HEON

Peptides for targeting apoptotic cells and uses thereof

Peptides for targeting apoptotic cells and uses thereof

LEE BYUNG-HEON

Polypeptide specifically bound to phosphatidylserine and the use thereof

Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof

K2B THERAPEUTICS INC

Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell

SHIFTBIO

Exosome-based anticancer agent

SHIFTBIO INC

Recombinant plasma membrane-based vesicle, for treating cancer

KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND

Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis

KIM IN SAN

Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof